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Abstract
Background: The Paeonia lactiflora extract (PLE) has been reported to have neuroprotective effect against
neurodegeneration that are induced by cellular stress such as oxidative stress. Its underlying mechanisms,
however, remain unclear. In latest decades, emerging evidence has suggested that epigenetic mechanisms
play a key role in gene regulation in response to the cellular stress. We investigated whether epigenetic
modulation was involved in neuronal cell death by the neurotoxicant, 1-Methyl-4-phenylpyridinium (MPP+),
and the neuroprotective effect of PLE.
Methods: Differentiated SH-SY5Y, which is a well-established dopaminergic cell line model, was treated with
0 ~ 200 μg/ml PLE for 4 h prior to MPP+ treatment. The effect of PLE on cell viability was determined by MTT
assays. Gene expression levels of oxidative stress responsive genes, such as Heme oxygenase 1 (HMOX1), and
histone modifiers, such as histone acetyltransferases (HATs) and deacetylases (HDACs) were measured by
quantitative RT PCR. In order to investigate the changes in epigenetic modifications, the acetylated lysine 9
(H3K9ac) and lysine 27 (H3K27ac) of Histone H3 were measured by western blot using histones extracted
from the cells.
Results: MPP+-induced cell death in SH-SY5Y cells was significantly reduced by PLE pretreatment in a dose-dependent
manner, indicating the potent neuroprotective effects of PLE. It was accompanied by induced expression of HMOX1.
MPP+ treatment increased the expression of HATs and consistently increased H3K9ac and H3K27ac of Histone H3. PLE
pretreatment impeded the changes in H3K9ac and H3K27ac, coincided with increased expression of HDAC5 without
changes in HAT expression.
Conclusions: The results suggested that MPP+-induced cell death in the dopaminergic SH-SY5Y cells was related
with transcriptional induction of HATs and increased histone H3 acetylation and that PLE might prevent the cells
from MPP+-induced cell death via tempering histone H3 acetylation.
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Background
Parkinson’s disease, the second most common neurode-
generative disorder following Alzheimer’s disease, is mainly
caused by progressive degeneration of dopaminergic neu-
rons [1]. One major risk factor leading to the degeneration
is cellular oxidative stress [2]. Oxidative stress is a cellular
oxidative imbalanced condition due to impaired mitochon-
drial function and elevated reactive oxygen species (ROS)
in the cell. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) and its metabolite, MPP+, has been used as oxida-
tive stressors that induce cell death in dopaminergic neu-
rons in vivo and in vitro, which mimic Parkinson’s disease
[2]. MPP+ enters dopaminergic neuronal cells via dopa-
mine transporters and induces mitochondria dysfunction.
It produces ROS [3] and releases cytochrome C (Cyt-C),
which activates caspase-3 and eventually, leads dopamin-
ergic neuronal cells to apoptosis [4]. MPP+-induced cell
system serves as a useful model to study the molecular
mechanism underlying loss of dopaminergic neurons and
therapeutic potentials.
Paeonia lactiflora Pall is one of the most commonly
used medicinal herbs across different traditional Chinese
medicine treatment for its anti-inflammatory and antioxi-
dant effects [5]. The herbal extract of this plant, PLE, has
been reported to have neuroprotective effects against oxi-
dative stress both in vivo [6] and in vitro [7, 8], in addition
to the main compounds such as albiflorin [9], paeoniflorin
[10–12], and paeonol [13, 14] that have been extracted
from this plant. It indicates its potentials to protect dopa-
minergic neurons from cell death and to attenuate the
process of Parkinson’s disease [6, 15, 16]. The underlying
molecular mechanism of PLE, however, remains elusive.
Recently, the emerging evidence on disease-preventive
and therapeutic effects of phytochemicals and herb ex-
tracts suggests that they mainly exert their functions, at
least in part, via epigenetic modulation [17]. Epigenetic
mechanisms such as DNA methylation and histone
modifications regulate gene expression via changes in
chromatin accessibility in response to environmental
stimuli such as oxidative stress [18]. Disturbed patterns
of histone acetylation as well as altered activity of HATs
and HDACs have been connected to chronic diseases,
including cancer and neurodegenerative diseases [18].
Cellular stress alters histone acetylation at specific resi-
dues such as histone H3 lysine9 and histone H4 lysine12
[19–21] and changes the activities of HDACs [22, 23],
suggesting the potential development of therapeutic stra-
tegies for neurodegenerative conditions [24–27]. However,
the epigenetic mechanism has been investigated on lim-
ited phytochemicals, for examples, curcumin enriched in
turmeric and sulforaphane enriched in broccoli, which
have effects on cell death and proliferation by inhibiting
HATs and HDACs, respectively [28–30]. Consequently, to
identify potential modulators of histone acetylation in
neuronal cells may provide novel therapeutic avenues
in neurodegenerative disorders.
Therefore, we investigated whether the neuroprotective
effects of PLE against oxidative stress in dopaminergic
neuron cells are mediated by epigenetic modulation. Using
the MPP+-induced SY5Y cell model, gene expression
involving the antioxidant pathway as well as histone
acetylation histone acetylation levels at histone H3 lysine




SH-SY5Y cell line was obtained from the Division of
Epigenomics and Cancer Risk Factors, German Cancer
Research Cancer (DKFZ, Heidelberg, Germany). The
cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Welgene, Daegu, South Korea) sup-
plemented with 10 % fetal bovine serum (FBS) (Gibco,
Gaithersberg, MD, USA), 100 units/ml penicillin, and
100 μg/ml streptomycin (Gibco, Gaithersberg, MD,
USA) with incubation at 37 °C in humidified 5 % CO2
and 95 % air. Upon cell passage, treatment of cells with
0.25 % trypsin-EDTA (Gibco, Gaithersberg, MD, USA),
was followed by quenching in DMEM whereupon the
cells were collected by centrifugation and rinsed with
phosphate buffered saline (PBS) (Sigma Aldrich, St.
Louis, MO, USA). The number of viable cells was
counted in a hemocytometer under a microscope after
excluding dead cells dyed with 0.4 % trypan blue solu-
tion (Gibco, Gaithersberg, MD, USA).
Cell differentiation and treatment
To obtain dopaminergic neuronal cells, SY5Y cells were
differentiated using DMEM with 10 μM retinoic acid
(Sigma Aldrich, St. Louis, MO, USA), 1 % FBS and100
units/ml penicillin, and 100 μg/ml streptomycin for
4 days. The medium was changed after 2 days during
differentiation. The differentiation was confirmed by the
increase in mRNA level of Tyrosine hydroxylase gene
(TH). Differentiated cells were treated with 0-2 mM
MPP+ (Sigma Aldrich, St. Louis, MO, USA) for 24 h to
optimize the concentration of MPP+ treatment. To inves-
tigate PLE effects, the differentiated cells were pretreated
with 0-200 μg/ml PLE for 4 h before 1 mM MPP+ treat-
ment. Lyophilized PLE extract was prepared by Hanpoong
Pham & Foods Co., Ltd (Jeonju, South Korea). Briefly,
300 g of Paeonia lactiflora was refluxed for 3 h in three
liters of 30 % ethanol, passed through 0.1 μm filter and va-
porized. PLE, obtained with 201.3 % yield, was dissolved in
dimethyl sulfoxide (DMSO) (Sigma Aldrich, St. Louis, MO,
USA) in 80 mg/ml PLE as a stock solution. The control
groups were supplemented with the same amount of DMSO
in the final maximum concentration less than 0.25 %.
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MTT assays
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbro-
mide (MTT) (Sigma Aldrich, St. Louis, MO, USA) was
dissolved in PBS at the concentration 5 mg/ml. The
MTT solution was added to one-tenth the original cul-
ture volume and the cells were incubated at 37 °C for
2 h. Then, DMSO was added in cells to convert soluble
MTT to insoluble purple formazan in mitochondria of
living cells. Viable cells forming formazan were mea-
sured at 562 nm using a microplate reader (Lab tech
international, Uckfield, UK).
RNA isolation and reverse transcription
Total RNA was isolated from cells by Trizol reagent
(Tel-test Inc, Friendswood, TX, USA). Reverse transcrip-
tion of 500 ng or 1 μg total RNA was performed for
cDNA synthesis. In brief, RNA samples were treated
with DNase I (Thermo Fisher Scientific, Waltham, MA,
USA) to remove genomic DNA, after which RNA samples
were incubated with dNTP (Thermo Fisher Scientific,
Waltham, MA, USA), oligo dT (Thermo Fisher Scientific,
Waltham, MA, USA), and reverse transcriptase (Thermo
Fisher Scientific, Waltham, MA, USA) to synthesize
cDNA, following the manufacturer’s protocol.
Quantitative reverse transcriptase (RT)-PCR
Quantitative RT-PCR was performed using SYBR green
mix (QIAGEN, Hilden, Germany) and Rotor-Gene Q
(QIAGEN, Hilden, Germany). RT PCR primer sequences
were the followings: TBP, 5’-AGCCAAGAGTGAAGAA
CAGTCC-3’ (forward) and 5’-CACAGCTCCCCACCA
TATTC-3’ (reverse); HMOX1, 5’-AACTTTCAGAAGGG
CCAGGT-3’ (forward) and 5’-GTAGACAGGGGCGAA
GACTG-3’ (reverse); Superoxide dismutase 2 (SOD2), 5’-
TCAATAAGGAACGGGGACAC-3’ (forward) and 5’-
ACACATCAATCCCCAGCAGT-3’ (reverse); E1A binding
protein p30 (EP300),5’-AGGGGCAACAAGAAGAAACC-
3’ (forward) and 5’-GAGGCGGATCACAAAGAAGA-3’
(reverse); CREB Binding Protein (CREBBP), 5’-CACTG
CAGCCAGTGAAACC-3’ (forward) and 5’-CATGCTG
GGCTTCTTCTTGT-3’ (reverse); HDAC5, 5’-AAGGT
CCTCATCGTGGACTG-3’ (forward) and 5’-GCACA
GAGGGGTCATTGTAGA-3’ (reverse). Amplification
procedure was 95 °C for 5 min, followed by 40 cycles
at 95 °C for 5 s, 60 °C for 10 s. Primers for TBP mRNA
were used to normalize mRNA expression. All experi-
ments were done in biological triplicate.
Histone extraction
Histones were extracted from SH-SY5Y cells by acid ex-
traction method in accordance with Shechter, et al.’s
protocol [31]. Cells were washed with 1X PBS and pel-
leted by centrifugation at 1000 g for 3 min. Cell pellets
were incubated in hypotonic lysis buffer (10 mM Tris,
1 mM KCl, 1 mM DTT, 1.5 mM MgCl2, 10 mM Sodium
butyrate, 1 mM PMSF, and 7X protease inhibitor cocktail
(Roche, Robert Rohrberg, Germany)) on a rotator at 4 °C
for 30 min. The nuclei were collected by centrifugation at
10,000 x g at 4 °C for 10 min, and the pelleted nuclei were
suspended in 0.4 N H2SO4 and placed on a rotator at 4 °C
overnight. Next day, the nuclear lysate was collected from
the supernatants after centrifugation at 14,620 x g at 4 °C
for 10 min to remove nuclear debris. Histones were
precipitated by TCA and washed with acetone-HCl and
acetone. Precipitated histones were collected by centrifu-
gation at 14,620 x g at 4 °C for 5 min, air-dried at room
temperature for 15 min and then dissolved in distilled
water. Histones were stored at -80 °C. All steps were
carried out by keeping samples on ice whenever possible.
Western blotting analysis
Isolated histones (2 or 3 μg per sample) were run on a
15 % PAGE. Histones were transferred to Nitrocellulose
(BioRad Laboratories, Hercules, CA, USA) or PVDF
(Millipore, Billerica, MA, USA) membranes. Membranes
were blocked in TBS-T with 5 % skim milk (Difco-
Laboratories, Detroit, Mich, USA) for 1 h at room
temperature and incubated overnight at 4 °C with primary
antibodies from Cell Signaling Technology, Danvers, MA,
USA. The following antibodies were used: rabbit anti-
bodies towards Histone H3 (1:1500), H3K9ac (1:1000) and
H3K27ac (1:1000) and mouse antibodies to Histone H4
(1:1000). After washing, rabbit or mouse IgG-HRP sec-
ondary antibodies (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) were incubated for 1 h at room temperature
and then developed at Pierce Enhanced chemilumines-
cence (ECL) kit (Thermo Scientific, Rockford, IL, USA).
The level of acetylated histone was quantified by Image J.
All experiments were done in biological triplicate.
Statistical analysis
Mean ± S.E.M. of cell viability and mRNA expression
levels were calculated by using Microsoft Excel 2010
(Microsoft, Redmond, WA, USA). One-way ANOVA ana-
lysis, followed by Duncan post hoc multiple comparisons,
was performed using SPSS (ver. 20.0, SPSS Inc., Chicago,
IL, USA). Statistical significance was set to p ≤ 0.05.
Results
MPP+-mediated changes of cell viability and SOD2 and
HMOX1 expression in differentiated SH-SY5Y cells
We analyzed cell viability of SH-SY5Y cells upon MPP+
treatment using MTT assays. Treatment with MPP+
concentrations ranging from 0 to 2 mM decreased cell
viability in a dose-dependent manner, down to about
52 % (Fig. 1a). To investigate whether MPP+ treatment
changed the expression of genes related with the cellular
anti-oxidative pathway in response to oxidative stress,
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mRNA expression levels of SOD2 and HMOX1 were
analyzed (Fig. 1b and c). Gene expression level of HMOX1
significantly increased at in 1 to 2 mM MPP+ treatment
and SOD2 significantly decreased at the 2 mM concentra-
tion. The results indicated that MPP+ indeed acted as a
neurotoxicant in dopaminergic neuronal cells by inducing
oxidative stress-mediated cell death. While the dose at
1 mM MPP+ is relatively low, it was sufficiently toxic to
significantly elevate HMOX1 gene expression and reduce
cell viability. Consequently, for subsequent experiment we
used the 1 mM dose to analyze the neuroprotective effects
provided by PLE.
Effects of PLE on MPP+-mediated cell death and HMOX1
expression
To investigate the effect of PLE against MPP+-induced
cell death, we pretreated SH-SY5Y cells with PLE in the
range of 0 to 200 μg/ml for 4 h prior to a 24 h 1 mM
MPP+ treatment. PLE pretreatment attenuated MPP+-in-
duced cell death in a dose-dependent manner (Fig. 2a).
Significantly, 200 μg/ml PLE recovered cell viability
up to 93 % compared with MPP+ nontreated group.
Interestingly, treatment with PLE did not alter SOD2
gene expression levels, a key component of the antioxi-
dant pathway (Fig. 2b), while HMOX1 gene expression
levels in 20-200 μg/ml PLE samples were significantly
increased 1.5 to 1.9 fold, respectively, when compared to
0 μg/ml PLE group (Fig. 2c).
Changes in acetylated levels of histones in MPP+ treated,
differentiated SH-SY5Y cells
To determine whether MPP+-induced cell death was a
result of epigenetic changes, we investigated alteration in
acetylation levels of histones and HAT gene expression
levels. The acetylation levels of H3K9 and H3K27 (relative
to total histones H3 and H4) were analyzed using western
blot analysis. When treating cells with MPP+ ranging from
0.5 to 2 mM, we observed a linear correlation with
increased acetylation levels of H3K9 and H3K27 (Fig. 3a).
In addition, gene expression levels of the major HAT
proteins, EP300 and CREBBP, were also increased in the
MPP+ treated samples (Fig. 3b). The results suggested that
increased HAT expression under neurotoxic condition led
to increased acetylation levels of H3K9 and H3K27.
Fig. 1 Changes of cell viability and mRNA expressions of SOD2 and HMOX1 in MPP+ treated cells. a MPP+ treatment decreased cell viability
depending on concentrations of MPP+. b MPP+ treatment decreased mRNA expressions of SOD2 related with clearing mitochondrial ROS. The
results confirmed MPP+ induces apoptosis by way of inhibition of mitochondrial complex. c MPP+ treatment increased mRNA expressions of
HMOX1 related with the antioxidant pathway. The results consent HMOX1 is induced by oxidative stress.; The data was indicated as the
mean ± S.E.M. P < 0.05 was defined statistical significance. One-way ANOVA followed by Duncan post hoc test
Fig. 2 Cell viability and mRNA expressions of SOD2 and HMOX1 in PLE and MPP+ treated cells. a PLE treatment recovered 1 mM MPP+ treated
cell viability depending on concentrations of PLE. The results suggested PLE has neuroprotective effects against MPP+-induced apoptosis. b PLE
treatment didn’t alter mRNA expressions of SOD2 in 1 mM MPP+ treated SH-SY5Y cells. c PLE treatment further activated mRNA expressions of
HMOX1 in 1 mM MPP+ treated SH-SY5Y cells. The results suggested PLE has neuroprotective effects on antioxidant function.; The data was
indicated as the mean ± S.E.M. P < 0.05 was defined statistical significance. One-way ANOVA followed by Duncan post hoc test
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H3K9ac and H3K27ac and HDAC5 and HATs mRNA
expressions in and MPP+ treated cells
Next, we determined whether pretreatment of PLE had
neuroprotective effect against MPP+-induced cell death
by means of epigenetic modulation. We investigated al-
teration of acetylation levels of histones and HATs and
HDACs gene expression levels. We measured acetylation
levels of H3K9 and H3K27 in MPP+ treated cells with
and without PLE using western blotting analysis. In the
PLE pretreated group, we observed that acetylation level
of H3K9 decreased, but not H3K27 acetylation (Fig. 4a).
The decreased acetylated H3K9 seemed to be due to
induction of the HDAC5 gene expression (Fig. 4b), rather
than altered EP300 and CREBBP expression (Fig. 4c), as
HDAC5 robustly increased with elevated PLE concentra-
tion. Our data suggest that HDAC5 decreased acetylation
levels of H3K9 in the 200 μg/ml PLE group, overriding
the effect from HATs, potentiation PLE as an anti-
neurotoxicant by tempering histone acetylation.
Discussion
In this study, we investigated whether MPP+ induced cell
death in the dopaminergic neuronal SH-SY5Y cells
through epigenetic modulation, and whether PLE had a
Fig. 3 Acetylation of H3K9 and H3K27 and mRNA expressions of HATs in MPP+ treated cells. a MPP+ treatment increased acetylation levels of
H3K9 and H3K27. b MPP+ treatment increased mRNA expressions of HATs such as EP300 and CREBBP. Figure 3 suggested HATs increase
acetylation levels of H3K9 and H3K27.; The data was indicated as the mean ± S.E.M. P < 0.05 was defined statistical significance. One-way
ANOVA followed by Duncan post hoc test
Fig. 4 H3K9ac and H3K27ac and HDAC5 and HATs mRNA expressions in PLE and MPP+ treated cells. a 200 μg/ml PLE treatment decreased
acetylation levels of H3K9 in 1 mM MPP+ treated cells. b PLE treatment did not significantly alter mRNA expressions of HATs in 1 mM MPP+
treated cells. c 200 μg/ml PLE treatment increased mRNA expressions of HDAC5 in 1 mM MPP+ treated cells. Figure 4 suggested HDAC5 rather
than HATs decreases acetylation levels of H3K9. The data was indicated as the mean ± S.E.M. P < 0.05 was defined statistical significance. One-way
ANOVA followed by Duncan post hoc test
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neuroprotective effect against cell death by reversing epi-
genetic changes. We demonstrated that MPP+-induced
cell death decreased SOD2 gene expression and increased
the HMOX1 gene expression levels. The results are con-
sistent with previous reports showing downregulation of
SOD2 and upregulation of HMOX1 under oxidative stress
[15, 32, 33]. PLE was recently reported to have protective
effect on neuronal cell death in studies both in vivo [6]
and in vitro [7]. The positive influence of PLE on dopa-
minergic neuronal cells potentiates its use in attenua-
ting the process of Parkinson’s disease [15, 16, 34].
However, the molecular mechanism of this protective
effect remains unclear.
One possibility is that the PLE effect involves the anti-
oxidant pathway. Our results demonstrated that PLE up-
regulated HMOX1 gene expression, while it did not alter
SOD2 gene expression. This indicates that the PLE effect
may be restricted to the HMOX1 pathway. HMOX1
gene encodes heme oxygenase 1 (HMOX1), which cata-
lyzes heme catabolism and plays a protective role as an
antioxidant. HMOX1 gene is activated in response to
oxidative stress, mainly via a major transcriptional factor,
Nuclear factor erythroid 2 related factor 2 (NRF2), which
exerts as a ROS scavenger [35]. A recent study showed
that Bromodomain protein 4 (BRD4) also transcriptio-
nally activates HMOX1 expression by targeting of SP1
binding sites in the HMOX1 promoter [36]. BRD4, an
acetylated histone-binding protein, is a key factor for
regulation of gene expression [37, 38]. siRNA-mediated
silencing of Bromodomain protein 4 (BRD4), in the ab-
sence of stress, resulted in downregulation of HMOX1
expression [36]. However, under oxidative stress, siRNA-
mediated knockdown of BRD4 upregulates HMOX1
expression further via downregulation of Kelch-like ECH-
associated protein 1 (KEAP1), which inhibits the degra-
dation of NRF2 [36]. The obvious connection between
hypoacetylated histone residues, especially H3K9, is
reflected by the silencing of BRD4 expression, since
BRD4 binds to particularly acetylated histones.
The neurprotective effect of PLE on MPP+-induced
cell death of the dopaminergic cells seems mediated by
epigenetic modulation, supported by our observation of
changes in acetylation of histone. Treatment of MPP+
increased gene expression levels of HATs such as EP300
and CREBBP, resulting in hyperacetylation of H3K9 and
H3K27. This is consistent with a previous report demon-
strating that neurotoxicity induced hyperacetylation and
transcriptional activation of pro-apoptotic genes, such as
PKC gamma and IL-8 [39]. Conversely, the pretreatment
of PLE increased gene expression of HDAC5, resulting
in hypoacetylation of H3K9. HDAC5 has been reported
to involve neuronal cell survival, proliferation, and dif-
ferentiation possibly via regulation of Myocyte enhancer
factor-2 (MEF2) [40–42]. The resulting hypoacetylation
upon PLE treatment may mimic the effect of BRD4
silencing under stress, leading to upregulated HMOX1
expression.
Our study of the neuroprotective properties of PLE
suggest that epigenetic modulation is a key component
of neurotoxic stress, and that therapeutic intervention
should consider this avenue of treatment in diseases
such as Parkinson’s disease.
Conclusions
MPP+-induced cell death in differentiated SH-SY5Y cells
was significantly reduced by PLE pretreatment in a dose-
dependent manner, accompanied by induced expression
of HMOX1. MPP+-treatment increased the expression of
HATs and consistently increased acetylation of H3K9 and
H3K27, while PLE pretreatment attenuated the hyperace-
tylation in H3K9, coincided with increased expression of
HDAC5 without changes in HAT expression. Our study
suggested that MPP+ treatment induced cell death in
dopaminergic SH-SY5Y cells via upregulation of HATs
and hyperacetylation of H3K9 and H3K27 and PLE
pretreatment may attenuate the cell death, in part, by
upregulation of HMOX1 expression through hypoacety-
lation of H3K9, possibly mediated by HDAC5 upregula-
tion. Further study is needed to identify direct targets
for HDAC5-mediated hypoacetylation of H3K9 in the
neuroprotective effects and to investigate whether it is
recapitulated in vivo.
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